Jasper Therapeutics (JSPR) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Jasper Therapeutics
Is Jasper Therapeutics a buy right now? The alternative data says hold. This JSPR stock analysis is built on the 25+ alternative data signals AltIndex tracks on Jasper Therapeutics every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 53/100: a Hold. The stock trades at $0.56 with a $19M market cap.
The soft spots over the past 90 days: web traffic down 10.7% to 4K monthly visits, and sentiment down 8.0% to 92/100. The rest of the signal set is holding steady, which keeps JSPR at a hold rather than a sell.
JSPR’s broader alt-data profile also covers headcount (39 employees, according to LinkedIn). Every signal links to its own page with full history, the JSPR technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on JSPR is just below.
Jasper Therapeutics AI Stock Analysis
Jasper Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for the treatment of diseases in hematopoietic cell transplant and gene therapy. With a primary focus on hematopoietic cell transplantation (HCT), Jasper Therapeutics seeks to transform the field through safer and more effective therapies.
Analysis generated October 6, 2026.
Recent Jasper Therapeutics Stock Alerts
|
Jasper Therapeutics | October 6 Price is down by -6.7% in the last 24h. |
|
Jasper Therapeutics | October 1 Price is up by 7.6% in the last 24h. |
|
Jasper Therapeutics | September 30 Price is down by -7.3% in the last 24h. |
|
Jasper Therapeutics | September 29 Price is up by 6.2% in the last 24h. |
Jasper Therapeutics Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 4K | 10.7% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 39 | 4.9% | |
| Sentiment | 92 | 8.0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 11 | 450.0% | |
| Stocktwits Mentions | 8 | 52.9% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 3K | 0.6% |
About Jasper Therapeutics (JSPR)
Jasper Therapeutics Inc (JSPR) is an innovative biopharmaceutical firm at the forefront of hematopoietic stem cell therapy, aimed at enhancing patient outcomes for severe diseases such as sickle cell disease and targeted blood cancers. The company's pioneering approach leverages advanced technologies to minimize transplant-related risks and address critical needs in the hematology market. With a robust intellectual property portfolio and strategic partnerships, Jasper is positioned to drive its clinical pipeline forward, underscoring its commitment to transformative advancements in regenerative medicine.
| Price | $0.56 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $19M |
| Year Range | $0 – $3 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Jasper Therapeutics News
View more →
Jasper Therapeutics beats Q2 expectations but shares fall after resultsAugust 17 - Yahoo Entertainment |
|
Jasper Therapeutics Announces Merger with Kira PharmaceuticalsJuly 16 - GlobeNewswire |
|
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder ValueJune 1 - GlobeNewswire |
|
Chronic Urticaria Clinical Trial Landscape Becomes Increasingly Crowded with 20+ Pharma Companies | DelveInsightAugust 5 - GlobeNewswire |
|
Kyverna Therapeutics’ (KYTX) Insights into Stiff Person Syndrome and BeyondJuly 9 - Yahoo Entertainment |
|
See Jasper Therapeutics’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for JSPR, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEJasper Therapeutics Earnings & Financial Performance
View all earnings →Jasper Therapeutics Insider Trading Activity
View all →| Crutcher Patrick J filed to sell 888 shares at $0.0. Jul 20 '26 |
| Ros Matthew E filed to sell 881 shares at $0.0. Jul 20 '26 |
| Shizuru Judith Anne filed to sell 41,000 shares at $0.0. Sep 22 '25 |
| MARTELL RON filed to sell 41,000 shares at $0.0. Sep 22 '25 |
| Lucas Svetlana filed to sell 20,000 shares at $0.0. Sep 22 '25 |
Jasper Therapeutics Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Jasper Therapeutics
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Tscan TherapeuticsTCRX |
$0.24 5.1% | $19M | 52 |
 |
Dyadic InternationalDYAI |
$0.46 3.8% | $18M | 53 |
 |
Vyne TherapeuticsVYNE |
$28.56 12.2% | $19M | 47 |
 |
SeaStar Medical HoldingICU |
$3.47 0.6% | $20M | 63 |
 |
Akari TherapeuticsAKTX |
$8.65 6.4% | $20M | 48 |
Explore Jasper Therapeutics Data
Frequently Asked Questions: Jasper Therapeutics (JSPR)
Jasper Therapeutics has an AltIndex AI Score of 53/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
53/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Jasper Therapeutics (JSPR) stock is $0.56 with a market cap of $19M.
As of today, Jasper Therapeutics’s PE (Price to Earnings) ratio is —.
View the latest Jasper Therapeutics insider transactions to see recent buying and selling activity by company executives and directors.
Check the Jasper Therapeutics congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The JSPR stock price chart above shows Jasper Therapeutics’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Jasper Therapeutics technical analysis for RSI, moving averages, and more.
See the stocks similar to Jasper Therapeutics section on this page for companies in the same industry ranked by market cap and AI Score.
